Drug profile · INN
smallpox and monkeypox vaccine (live modified vaccinia virus ankara)
IMVANEX
smallpox and monkeypox vaccine (live modified vaccinia virus ankara) (IMVANEX) is a biological vaccine - induces immune response.
EMA: approved Antiinfectives for systemic use (J07) J07BX
Patents linked 3
Pipeline programs 3
News articles 0
Drug details — smallpox and monkeypox vaccine (live modified vaccinia virus ankara)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 3
- Programs
- 3
- Data quality
- 0.83
Quick answer
smallpox and monkeypox vaccine (live modified vaccinia virus ankara) (IMVANEX) is a biological vaccine - induces immune response.
Key facts
INN smallpox and monkeypox vaccine (live modified vaccinia virus ankara)
Brand IMVANEX
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BX
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is smallpox and monkeypox vaccine (live modified vaccinia virus ankara)?
smallpox and monkeypox vaccine (live modified vaccinia virus ankara) (IMVANEX) is a biological vaccine - induces immune response.
What is the brand name for smallpox and monkeypox vaccine (live modified vaccinia virus ankara)?
IMVANEX is a marketed brand name for smallpox and monkeypox vaccine (live modified vaccinia virus ankara). Check FDA Drugs@FDA for the current US label holder and prescribing information.